Please assess the completion status of the following clinical trial:

Trial Title: Satavaptan Dose-Ranging Study in Hyponatraemic Patients With Cirrhotic Ascites

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Cirrhosis of the liver confirmed by ultrasound, endoscopic examination, or biochemical evidence~* Moderate or tense ascites~* Patients with hyponatremia, defined as a serum sodium concentration of ≤130 mmol/L~The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).